4
Changes in Ownership
BioAge Labs, Inc. Filed Acc 0001415889-24-024040
Options or other derivatives
- Chief Operating Officer acquired 276,523 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Morgen Eric · Chief Operating Officer
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-25 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +4,952 | 4,952 | I |
| 2024-04-17 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +257,973 | 257,973 | D |
| 2024-04-17 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +13,598 | 13,598 | I |
Loading xslF345X05/form4-09272024_080956.xml…